What It Is
PRA-IG1 susceptibility refers to a genetic susceptibility marker associated with increased risk for a progressive retinal atrophy phenotype, rather than a simple diagnosis based only on visible eye signs.
Also Called: PRA-IG1; IG1 PRA susceptibility; Italian Greyhound PRA susceptibility
Abbreviation: PRA-IG1
Breeds Affected: Most relevant where the breed-specific susceptibility test is recognized. Do not apply this marker broadly to every PRA-risk breed.
Breed Risk Note: Because this is labeled as susceptibility, results should be interpreted carefully with breed, pedigree, clinical eye exams, and the testing lab’s guidance.
The Idiot-Proof Explanation
This is not quite the same as saying “this dog is blind” or even “this dog absolutely will go blind.” It is a genetic risk/susceptibility result tied to a PRA problem. Translation: breeders need to understand the test before making puppies, and owners still need eye monitoring if risk is present.
What Causes It
PRA-IG1 susceptibility is treated as a genetic risk marker connected to inherited retinal degeneration. It belongs under the PRA umbrella but should be interpreted more carefully than a straightforward affected/carrier label for a simple recessive test.
Because susceptibility markers can be more nuanced, the testing lab’s interpretation and veterinary ophthalmology findings matter.
- This is a genetic risk/susceptibility result, not a couch diagnosis of blindness.
- Breed-specific interpretation matters.
- Eye exams remain important for clinical status.
Bottom line: the word susceptibility is doing work here. Do not ignore it and do not overstate it.
What This Means for Life With This Dog
For owners, this means the dog may need eye monitoring and a realistic plan if vision changes appear.
For breeders, it means do not treat the result like trivia. Ask what the result means for pairings, risk, and the breed’s genetic diversity.
Can It Be Fixed?
The genetic risk cannot be cured. Management depends on the dog’s actual vision, ophthalmology findings, and breeding status.
Symptoms Owners May Notice
May have no obvious early signs: A risk result can exist before an owner notices vision problems. Very helpful of genetics to be invisible until it is inconvenient.
Night vision changes: If PRA develops, low-light vision may be affected early.
Progressive vision loss: Affected dogs may gradually lose useful vision over time.
Abnormal eye screening: A veterinary ophthalmology exam may detect retinal changes that are not obvious at home.
Treatment Options
Lab result interpretation: Review the test result with the testing lab’s explanation and your veterinarian. Susceptibility language matters and should not be flattened into yes/no folklore.
Ophthalmology monitoring: Eye exams help separate genetic risk from current clinical disease.
Breeding risk management: Breeding decisions should account for the marker, the mate’s result, the dog’s eye status, and breed diversity. Simple panic-culling is not a strategy either.
Recovery and Aftercare
Aftercare means periodic eye monitoring, record-keeping, and careful breeding decisions if the dog is intact. For pet owners, the goal is preparation, not panic.
What Happens If You Wait
Ignoring a risk marker defeats the entire point of testing.
The test exists so people can make smarter decisions before affected dogs are produced or before vision loss catches the household unprepared.
Cost Reality Check
Costs are mostly testing, interpretation, eye screening, and monitoring unless the dog develops clinical eye disease.
| Care Level | What It May Include | Estimated Cost |
|---|---|---|
| Initial workup | Genetic test, result review, and baseline eye screening. | $100-$500 |
| Ongoing management | Follow-up eye exams and breeding counseling or additional testing. | $200-$1,000+ |
| Severe case | Specialist diagnostics or management of clinical retinal disease if it develops. | $1,000-$4,000+ |
Budget Reality Check
| Budget Item | Estimated Cost |
|---|---|
| PRA-IG1 susceptibility test | $60-$250+ |
| Eye screening | $50-$250+ |
| Ophthalmology consult | $250-$700+ |
Lifetime Cost Reality
| Case Pattern | Possible Lifetime Cost |
|---|---|
| Risk testing only | $60-$500+ |
| Monitoring case | $300-$2,000+ |
| Clinical PRA case | $1,000-$6,000+ |
Tell Me What I Should Really Expect
PRA-IG1 susceptibility is a genetics page that needs nuance, not panic.
This result should guide smarter screening and breeding choices. It should not be ignored, exaggerated, or used as a substitute for an actual eye exam. Tiny detail, enormous difference, as usual.